Literature DB >> 19838624

Alzheimer's disease and endothelial dysfunction.

Giuseppe Bomboi1, Lorenzo Castello, Francesco Cosentino, Franco Giubilei, Francesco Orzi, Massimo Volpe.   

Abstract

Recent studies suggest strong interactions between cerebrovascular and Alzheimer's disease (AD) pathology. These conditions share common risk factors and individuals having both frequently show greater cognitive impairment than those affected by only one disease. Many studies point to early vascular dysregulations in AD. The exchange between vascular and neural cells occurs through mechanisms not completely understood, involving interactions among endothelial, glial, neuronal and smooth muscle cells within the neurovascular unit. Studies suggest that the dysregulation of the unit is likely associated with hypertension and other systemic diseases. Associations between hypertension and cognitive decline are not established, but other variables associated with hypertension could create a causal link. Many studies have lacked a consistent, quantitative neuropsychological approach for assessing cognitive functions. This approach is reductive, as the need for a formal neuropsychological assessment has gained broad recognition, and the definition of dementia has gone through revision processes, which are in progress.

Entities:  

Mesh:

Year:  2009        PMID: 19838624     DOI: 10.1007/s10072-009-0151-6

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  70 in total

1.  Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene.

Authors:  P A Marsden; H H Heng; S W Scherer; R J Stewart; A V Hall; X M Shi; L C Tsui; K T Schappert
Journal:  J Biol Chem       Date:  1993-08-15       Impact factor: 5.157

2.  Dementia and disability outcomes in large hypertension trials: lessons learned from the systolic hypertension in the elderly program (SHEP) trial.

Authors:  M Di Bari; M Pahor; L V Franse; R I Shorr; J Y Wan; L Ferrucci; G W Somes; W B Applegate
Journal:  Am J Epidemiol       Date:  2001-01-01       Impact factor: 4.897

3.  Vasodilation to bradykinin is mediated by an ouabain-sensitive pathway as a compensatory mechanism for impaired nitric oxide availability in essential hypertensive patients.

Authors:  S Taddei; L Ghiadoni; A Virdis; S Buralli; A Salvetti
Journal:  Circulation       Date:  1999-09-28       Impact factor: 29.690

4.  Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

Authors:  J A Staessen; R Fagard; L Thijs; H Celis; G G Arabidze; W H Birkenhäger; C J Bulpitt; P W de Leeuw; C T Dollery; A E Fletcher; F Forette; G Leonetti; C Nachev; E T O'Brien; J Rosenfeld; J L Rodicio; J Tuomilehto; A Zanchetti
Journal:  Lancet       Date:  1997-09-13       Impact factor: 79.321

5.  15-year longitudinal study of blood pressure and dementia.

Authors:  I Skoog; B Lernfelt; S Landahl; B Palmertz; L A Andreasson; L Nilsson; G Persson; A Odén; A Svanborg
Journal:  Lancet       Date:  1996-04-27       Impact factor: 79.321

6.  Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.

Authors: 
Journal:  JAMA       Date:  1991-06-26       Impact factor: 56.272

7.  Reduced cerebral blood flow response and compensation among patients with untreated hypertension.

Authors:  J R Jennings; M F Muldoon; C Ryan; J C Price; P Greer; K Sutton-Tyrrell; F M van der Veen; C C Meltzer
Journal:  Neurology       Date:  2005-04-26       Impact factor: 9.910

Review 8.  The role of cerebral ischemia in Alzheimer's disease.

Authors:  R N Kalaria
Journal:  Neurobiol Aging       Date:  2000 Mar-Apr       Impact factor: 4.673

9.  Impairment of the nitric oxide-mediated vasodilator response to mental stress in hypertensive but not in hypercholesterolemic patients.

Authors:  C Cardillo; C M Kilcoyne; R O Cannon; J A Panza
Journal:  J Am Coll Cardiol       Date:  1998-11       Impact factor: 24.094

10.  Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. EURODEM Incidence Research Group and Work Groups. European Studies of Dementia.

Authors:  L J Launer; K Andersen; M E Dewey; L Letenneur; A Ott; L A Amaducci; C Brayne; J R Copeland; J F Dartigues; P Kragh-Sorensen; A Lobo; J M Martinez-Lage; T Stijnen; A Hofman
Journal:  Neurology       Date:  1999-01-01       Impact factor: 9.910

View more
  15 in total

1.  Immersion autometallographic demonstration of pathological zinc accumulation in human acute neural diseases.

Authors:  Lin Zhu; Yong Tang; Han-Dong Wang; Zhi-Yuan Zhang; Hao Pan
Journal:  Neurol Sci       Date:  2011-11-11       Impact factor: 3.307

2.  The impact of hypertension on cerebral perfusion and cortical thickness in older adults.

Authors:  Michael L Alosco; John Gunstad; Xiaomeng Xu; Uraina S Clark; Donald R Labbe; Hannah H Riskin-Jones; Gretel Terrero; Nicolette F Schwarz; Edward G Walsh; Athena Poppas; Ronald A Cohen; Lawrence H Sweet
Journal:  J Am Soc Hypertens       Date:  2014-04-13

Review 3.  The neglected co-star in the dementia drama: the putative roles of astrocytes in the pathogeneses of major neurocognitive disorders.

Authors:  W K Jo; A C K Law; S K Chung
Journal:  Mol Psychiatry       Date:  2014-01-07       Impact factor: 15.992

4.  Attenuation of vascular dementia by sodium butyrate in streptozotocin diabetic rats.

Authors:  Bhupesh Sharma; Nirmal Singh
Journal:  Psychopharmacology (Berl)       Date:  2011-01-12       Impact factor: 4.530

5.  Type 1 diabetes predisposes to enhanced gingival leukocyte margination and macromolecule extravasation in vivo.

Authors:  C Sima; K Rhourida; T E Van Dyke; R Gyurko
Journal:  J Periodontal Res       Date:  2010-12       Impact factor: 4.419

6.  Age-related changes in cerebrovascular reactivity and their relationship to cognition: A four-year longitudinal study.

Authors:  Shin-Lei Peng; Xi Chen; Yang Li; Karen M Rodrigue; Denise C Park; Hanzhang Lu
Journal:  Neuroimage       Date:  2018-03-19       Impact factor: 6.556

7.  Therapeutic potential of intranasal photobiomodulation therapy for neurological and neuropsychiatric disorders: a narrative review.

Authors:  Farzad Salehpour; Sevda Gholipour-Khalili; Fereshteh Farajdokht; Farzin Kamari; Tomasz Walski; Michael R Hamblin; Joseph O DiDuro; Paolo Cassano
Journal:  Rev Neurosci       Date:  2020-04-28       Impact factor: 4.353

Review 8.  Activation of PARP by oxidative stress induced by β-amyloid: implications for Alzheimer's disease.

Authors:  Rosella Abeti; Michael R Duchen
Journal:  Neurochem Res       Date:  2012-10-18       Impact factor: 3.996

9.  Cardiorenal metabolic syndrome and diabetic cognopathy.

Authors:  M R Hayden; W A Banks; G N Shah; Z Gu; J R Sowers
Journal:  Cardiorenal Med       Date:  2013-11-29       Impact factor: 2.041

Review 10.  Neurovascular dysfunction, inflammation and endothelial activation: implications for the pathogenesis of Alzheimer's disease.

Authors:  Paula Grammas
Journal:  J Neuroinflammation       Date:  2011-03-25       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.